CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company
Inhibikase Therapeutics, Inc.
Sign in to watch- Ticker
- IKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263407249
- Phone
- (302) 295-3800
- Business address
- 1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
- 3 Insider Initial Statement of Ownership
- 8-K/A Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
Page 11 of 19 · 370 filings